LABAs are useful for relieving which type of symptoms?

Long-acting beta-agonists (LABAs) are primarily used for controlling nocturnal symptoms in asthma management. These medications work by relaxing the muscles around the airways for an extended period, typically providing relief for up to 12 hours or more. Their prolonged action makes them effective in preventing nighttime awakenings and allowing for better sleep quality in patients with asthma.

While LABAs play a role in managing chronic asthma symptoms and can help with overall control of the disease, they are not recommended for immediate relief of acute symptoms or attacks, as they do not act quickly enough to address sudden wheezing or shortness of breath. This property distinguishes them from short-acting beta-agonists (SABAs), which are specifically designed for immediate relief of asthma symptoms. In terms of chronic cough management, while LABAs can contribute to overall symptom control, they are not primarily indicated for managing cough directly. Thus, their principal benefit lies in their ability to control nocturnal symptoms and provide long-term asthma control when used in conjunction with other controller medications.